This bill focuses on higher education funding for amyotrophic lateral sclerosis (ALS) research in Minnesota. It cancels a previous appropriation of $15,000,000 from the general fund that was designated for the Office of Higher Education and instead allocates the same amount to the Board of Regents of the University of Minnesota. This funding is intended to support a collaborative partnership with the Mayo Clinic for ongoing ALS research, with the aim of improving the lives of individuals affected by the disease and ultimately finding a cure. The bill specifies that this is a one-time appropriation and that any unencumbered balances will not cancel until June 30, 2029.

Additionally, the bill requires the Board of Regents to submit annual reports to the legislature starting January 15, 2026, detailing how the appropriated funds have been utilized in the collaborative research efforts. Furthermore, the bill repeals a previous section of law (Laws 2022, chapter 42, section 2) that outlined earlier appropriations and grant programs for ALS research, thereby streamlining the funding process and focusing resources on the new partnership with the Mayo Clinic.